High prevalence of distress in patients after allogeneic hematopoietic SCT: Fear of progression is associated with a younger age

Bone Marrow Transplantation

Volumn 49, Issue 4, 2014, Pages 581-584

  Hefner, J ^a   Kapp, M ^b   Drebinger, K ^a   Dannenmann, A ^a   Einsele, H ^b   Grigoleit, G U ^b   Faller, H ^a   Csef, H ^a   Mielke, S ^b  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

Author keywords

Allogeneic hematopoietic SCT; Anxiety; Depression; Distress; Fear of progression; Psychiatric care

Indexed keywords

ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT;

ACUTE GRAFT VERSUS HOST DISEASE; ADULT; AGE DISTRIBUTION; AGED; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ANXIETY; ANXIETY DISORDER; ARTICLE; CHRONIC GRAFT VERSUS HOST DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; CYTOMEGALOVIRUS INFECTION; DEPRESSION; DISEASE COURSE; DISTRESS SYNDROME; FAMILY LIFE; FEAR; FEMALE; HEMATOLOGIC MALIGNANCY; HUMAN; MALE; OUTPATIENT DEPARTMENT; PILOT STUDY; POSTTRAUMATIC STRESS DISORDER; PREVALENCE; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; PSYCHOTHERAPY; QUESTIONNAIRE; SYMPTOMATOLOGY; VERY ELDERLY; VIRUS REACTIVATION; AGE; ALLOTRANSPLANTATION; ETIOLOGY; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; MENTAL STRESS; MIDDLE AGED; PROCEDURES; PSYCHOLOGY; QUALITY OF LIFE; YOUNG ADULT;

ADULT; AGE FACTORS; AGED; ANXIETY; CROSS-SECTIONAL STUDIES; DISEASE PROGRESSION; FEMALE; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; PREVALENCE; QUALITY OF LIFE; QUESTIONNAIRES; STRESS, PSYCHOLOGICAL; TRANSPLANTATION, HOMOLOGOUS; YOUNG ADULT;

EID: 84897554850     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2013.228     Document Type: Article

References (40)

1. Armitage JO. Bone marrow transplantation. N Engl J Med 1994; 330: 827-838.
2. Appelbaum FR. The current status of hematopoietic cell transplantation. Annu Rev Med 2003; 54: 491-512.
3. Sullivan KM. Current status of bone marrow transplantation. Transplant Proc 1989; 21(Suppl 1): 41-50.
4. Baldomero H, Gratwohl M, Gratwohl A, Tichelli A, Niederwieser D, Madrigal A et al. The EBMT activity survey 2009: trends over the past 5 years. Bone Marrow Transplant 2011; 46: 485-501.
5. Passweg JR, Baldomero H, Gratwohl A, Bregni M, Cesaro S, Dreger P et al. The EBMT activity survey: 1990-2010. Bone Marrow Transplant 2012; 47: 906-923.
6. Bearman SI, Appelbaum FR, Buckner CD, Petersen FB, Fisher LD, Clift RA et al. Regimen-related toxicity in patients undergoing bone marrow transplantation. J Clin Oncol 1988; 6: 1562-1568.
7. Barrett AJ, Savani BN. Stem cell transplantation with reduced-intensity conditioning regimens: a review of ten years experience with new transplant concepts and new therapeutic agents. Leukemia 2006; 20: 1661-1672.
8. Passweg JR, Baldomero H, Bregni M, Cesaro S, Dreger P, Duarte RF et al. Hematopoietic SCT in Europe: data and trends in 2011. Bone Marrow Transplant 2013; 48: 1161-1167.
9. Harousseau JL. Role of stem cell transplantation. Hematol Oncol Clin N Am 2007; 21: 1157-1174.
10. Prieto JM, Blanch J, Atala J, Carreras E, Rovira M, Cirera E et al. Psychiatric morbidity and impact on hospital length of stay among hematologic cancer patients receiving stem-cell transplantation. J Clin Oncol 2002; 20: 1907-1917.
11. Holland JC. NCCN practice guidelines for the management of psychosocial distress. National Comprehensive Cancer Network. Oncology (Williston Park) 1999; 13: 113-147.
12. Jim HS, Syrjala KL, Rizzo D. Supportive care of hematopoietic cell transplant patients. Biol Blood Marrow Transplant 2012; 18(Suppl): S12-S16.
13. Mosher CE, Redd WH, Rini CM, Burkhalter JE, DuHamel KN. Physical, psychological, and social sequelae following hematopoietic stem cell transplantation: a review of the literature. Psycho-Oncology 2009; 18: 113-127.
14. Syrjala KL, Langer SL, Abrams JR, Storer B, Sanders JE, Flowers ME et al. Recovery and long-term function after hematopoietic cell transplantation for leukemia or lymphoma. JAMA 2004; 291: 2335-2343.
15. Prieto JM, Atala J, Blanch J, Carreras E, Rovira M, Cirera E et al. Patient-rated emotional and physical functioning among hematologic cancer patients during hospitalization for stem-cell transplantation. Bone Marrow Transplant 2005; 35: 307-314.
16. Lee SJ, Loberiza FR, Antin JH, Kirkpatrick T, Prokop L, Alyea EP et al. Routine screening for psychosocial distress following hematopoietic stem cell transplantation. Bone Marrow Transplant 2005; 35: 77-83.
17. DuHamel KN, Ostrof J, Ashman T, Winkel G, Mundy EA, Keane TM et al. Construct validity of the posttraumatic stress disorder checklist in cancer survivors: analyses based on two samples. Psychol Assess 2004; 16: 255-266.
18. Jacobsen PB, Sadler IJ, Booth-Jones M, Soety E, Weitzner MA, Fields KK. Predictors of posttraumatic stress disorder symptomatology following bone marrow transplantation for cancer. J Consult Clin Psychol 2002; 70: 235-240.
19. Widows MR, Jacobsen PB, Fields KK. Relation of psychological vulnerability factors to posttraumatic stress disorder symptomatology in bone marrow transplant recipients. Psychosom Med 2000; 62: 873-882.
20. Smith MY, Redd W, DuHamel K, Vickberg SJ, Ricketts P. Validation of the PTSD Checklist-Civilian Version in survivors of bone marrow transplantation. J Trauma Stress 1999; 12: 485-499.
21. Spitzer RL, Kroenke K, Williams JB, Lowe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med 2006; 166: 1092-1097.
22. Lowe B, Decker O, Muller S, Brahler E, Schellberg D, Herzog W et al. Validation and standardization of the Generalized Anxiety Disorder Screener (GAD-7) in the general population. Med Care 2008; 46: 266-274.
23. Mehnert A, Herschbach P, Berg P, Henrich G, Koch U. Fear of progression in breast cancer patients - validation of the short form of the Fear of Progression Questionnaire (FoP-Q-SF). Z Psychosom Med Psychother 2006; 52: 274-288.
24. Herschbach P, Berg P, Dankert A, Duran G, Engst-Hastreiter U, Waadt S et al. Fear of progression in chronic diseases: psychometric properties of the Fear of Progression Questionnaire. J Psychosom Res 2005; 58: 505-511.
25. Spitzer RL, Kroenke K, Williams JB. Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire. JAMA 1999; 282: 1737-1744.
26. Lowe B, Kroenke K, Herzog W, Grafe K. Measuring depression outcome with a brief self-report instrument: sensitivity to change of the Patient Health Questionnaire (PHQ-9). J Affect Disord 2004; 81: 61-66.
27. Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med 2001; 16: 606-613.
28. National Center for PTSD, Boston, MA, USA: Posttraumatic Stress Disorder Checklist (PCL), published 1993 in International Society for Traumatic Stress Studies: http://www.istss.org/PosttraumaticStressDisorderChecklist/5361.htm.
29. Ruggiero KJ, Del Ben K, Scotti JR, Rabalais AE. Psychometric properties of the PTSD Checklist-Civilian Version. J Trauma Stress 2003; 16: 495-502.
30. Blanchard EB, Jones-Alexander J, Buckley TC, Forneris CA. Psychometric properties of the PTSD Checklist (PCL). Behav Res Ther 1996; 34: 669-673.
31. Deck R, Röckelein E. Zur Erhebung soziodemographischer und sozialmedizinischer Indikatoren in den rehabilitationswissenschaftlichen Forschungsverbünden. DRV-Schriften 1999; 16: 84-102.
32. Zabora J, BrintzenhofeSzoc K, Curbow B, Hooker C, Piantadosi S. The prevalence of psychological distress by cancer site. Psycho-Oncology 2001; 10: 19-28.
33. Carlson LE, Angen M, Cullum J, Goodey E, Koopmans J, Lamont L et al. High levels of untreated distress and fatigue in cancer patients. Br J Cancer 2004; 90: 2297-2304.
34. Hoodin F, Zhao L, Carey J, Levine JE, Kitko C. Impact of psychological screening on routine outpatient care of hematopoietic cell transplantation survivors. Biol Blood Marrow Transplant 2013; 19: 1493-1497.
35. Sun CL, Francisco L, Baker KS, Weisdorf DJ, Forman SJ, Bhatia S. Adverse psychological outcomes in long-term survivors of hematopoietic cell transplantation: a report from the Bone Marrow Transplant Survivor Study (BMTSS). Blood 2011; 118: 4723-4731.
36. Prieto JM, Atala J, Blanch J, Carreras E, Rovira M, Cirera E et al. Role of depression as a predictor of mortality among cancer patients after stem-cell transplantation. J Clin Oncol 2005; 23: 6063-6071.
37. Loberiza Jr. FR, Rizzo JD, Bredeson CN, Antin JH, Horowitz MM, Weeks JC et al. Association of depressive syndrome and early deaths among patients after stem-cell transplantation for malignant diseases. J Clin Oncol 2002; 20: 2118-2126.
38. Colon EA, Callies AL, Popkin MK, McGlave PB. Depressed mood and other variables related to bone marrow transplantation survival in acute leukemia. Psychosomatics 1991; 32: 420-425.
39. Park JE, Kim KI, Yoon SS, Hahm BJ, Lee SM, Yoon JH et al. Psychological distress as a negative survival factor for patients with hematologic malignancies who underwent allogeneic hematopoietic stem cell transplantation. Pharmacotherapy 2010; 30: 1239-1246.
40. McGregor BA, Syrjala KL, Dolan ED, Langer SL, Redman M. The effect of pre-transplant distress on immune reconstitution among adult autologous hematopoietic cell transplantation patients. Brain Behav Immun 2013; 30(Suppl): S142-S148.